{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:13:28Z","timestamp":1788902008780,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>\n                    Hyperpolarized [1-\n                    <jats:sup>13<\/jats:sup>\n                    C]pyruvate MRI enables real-time assessment of tumor glycolytic flux. We report 2 women with suspected ovarian cancer examined preoperatively with hyperpolarized [1-\n                    <jats:sup>13<\/jats:sup>\n                    C]-pyruvate MRI and FDG PET\/CT. In a 49-year-old woman with a right adnexal mass, FDG uptake was limited, and hyperpolarized imaging demonstrated minimal lactate production; histopathology revealed a benign fibroma. In a 51-year-old woman with advanced disease, FDG PET\/CT showed extensive metabolically active tumors. Hyperpolarized imaging demonstrated markedly increased lactate-to-pyruvate conversion within solid tumor components. Histopathology confirmed high-grade serous carcinoma. These cases illustrate the potential complementary role of hyperpolarized [1-\n                    <jats:sup>13<\/jats:sup>\n                    C]pyruvate MRI in differentiating benign from malignant adnexal masses.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006625","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:00:53Z","timestamp":1788901253000},"page":"885-887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hyperpolarized [1-13C]-Pyruvate MRI Differentiates Benign Fibroma From High-grade Serous Carcinoma"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0728-3167","authenticated-orcid":false,"given":"Malene","family":"Aastrup","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, MR Research Centre, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-9870","authenticated-orcid":false,"given":"Esben S\u00f8vs\u00f8 Szocska","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, MR Research Centre, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-1173","authenticated-orcid":false,"given":"Katrine","family":"Fuglsang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Gynaecological Surgery, Aarhus University Hospital"},{"name":"Department of Clinical Medicine, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-8794","authenticated-orcid":false,"given":"Kirsten","family":"Bouchelouche","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6258-1299","authenticated-orcid":false,"given":"Jack J.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, MR Research Centre, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"R1-20260908","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jmri.70084","article-title":"Technologies and strategies for metabolic and molecular imaging with hyperpolarized MRI","volume":"63","author":"Khan","year":"2026","journal-title":"J Magn Reson Imaging"},{"key":"R2-20260908","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/mrm.29875","article-title":"Current methods for hyperpolarized [1-(13)C]pyruvate MRI human studies","volume":"91","author":"Larson","year":"2024","journal-title":"Magn Reson Med"},{"key":"R3-20260908","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1021\/bi501225t","article-title":"Hyperpolarized magnetic resonance as a sensitive detector of metabolic function","volume":"53","author":"Comment","year":"2014","journal-title":"Biochemistry"},{"key":"R4-20260908","doi-asserted-by":"crossref","first-page":"e71996","DOI":"10.1371\/journal.pone.0071996","article-title":"Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data","volume":"8","author":"Hill","year":"2013","journal-title":"PLoS One"},{"key":"R5-20260908","doi-asserted-by":"crossref","first-page":"e230005","DOI":"10.1148\/rycan.230005","article-title":"Hyperpolarized carbon 13 MRI: clinical applications and future directions in oncology","volume":"5","author":"Deen","year":"2023","journal-title":"Radiol Imaging Cancer"},{"key":"R6-20260908","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/cancers14020335","article-title":"Hyperpolarized (13)C-pyruvate metabolism as a surrogate for tumor grade and poor outcome in renal cell carcinoma-a proof of principle study","volume":"14","author":"Ursprung","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R7-20260908","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.semnuclmed.2021.09.001","article-title":"Hyperpolarized MRI - an update and future perspectives","volume":"52","author":"J\u00f8rgensen","year":"2022","journal-title":"Semin Nucl Med"},{"key":"R8-20260908","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1073\/pnas.1913841117","article-title":"Imaging breast cancer using hyperpolarized carbon-13 MRI","volume":"117","author":"Gallagher","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"R9-20260908","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1148\/radiol.2019182391","article-title":"Hyperpolarized (13)C MRI: state of the art and future directions","volume":"291","author":"Wang","year":"2019","journal-title":"Radiology"},{"key":"R10-20260908","doi-asserted-by":"crossref","first-page":"198ra108","DOI":"10.1126\/scitranslmed.3006070","article-title":"Metabolic imaging of patients with prostate cancer using hyperpolarized [1-(1)(3)C]pyruvate","volume":"5","author":"Nelson","year":"2013","journal-title":"Sci Transl Med"},{"key":"R11-20260908","doi-asserted-by":"crossref","first-page":"10855","DOI":"10.1158\/0008-5472.CAN-06-2564","article-title":"Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis","volume":"66","author":"Golman","year":"2006","journal-title":"Cancer Res"},{"key":"R12-20260908","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/RLU.0000000000005534","article-title":"First-in-human: simultaneous hyperpolarized 1- 13 C-pyruvate magnetic resonance spectroscopy and 18 F-FDG PET (hyperPET) imaging of a patient with lymphoma","volume":"50","author":"Loft","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"suppl 1","key":"R13-20260908","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijgo.70282","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2025 update","volume":"171","author":"Renz","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R14-20260908","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"key":"R15-20260908","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.ejso.2021.03.233","article-title":"Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer - a systematic review","volume":"47","author":"Engbersen","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R16-20260908","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13244-023-01577-5","article-title":"O-RADS MRI risk stratification system: pearls and pitfalls","volume":"15","author":"Nougaret","year":"2024","journal-title":"Insights Imaging"},{"key":"R17-20260908","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1007\/s00330-021-08054-x","article-title":"O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort","volume":"31","author":"Thomassin-Naggara","year":"2021","journal-title":"Eur Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:00:56Z","timestamp":1788901256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006625","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"2026-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}